Diabetes and obesity: the role of stress in the development of cancer
- PMID: 38831236
- DOI: 10.1007/s12020-024-03886-1
Diabetes and obesity: the role of stress in the development of cancer
Abstract
Diabesity is a condition where an individual has both diabetes and obesity, which can lead to severe complications including cardiovascular disease, a leading cause of mortality. Recently, cancer has become a leading cause of excess hospitalizations, and both diabetes and obesity are associated with a higher risk of developing several types of cancer. In this review, we propose that chronic stress significantly increases this association. Managing diabetes and obesity is challenging as they both cause significant distress. The relationship between stress and cancer is interconnected, with anxiety and depression being common in cancer patients. Cancer diagnosis and treatment can cause lasting changes in the body's neuroendocrine system, with stress causing an excessive release of catecholamines and prostaglandins in patients undergoing cancer surgery, which promotes the spread of cancer to other parts of the body. Furthermore, stress could significantly increase the risk of cancer in patients with diabetes, obesity, or both.
Keywords: Cancer; Diabetes mellitus; Non-communicable chronic disease; Obesity; Stress.
© 2024. The Author(s).
Similar articles
-
Feeding the critically ill obese patient: a systematic review protocol.JBI Database System Rev Implement Rep. 2015 Oct;13(10):95-109. doi: 10.11124/jbisrir-2015-2458. JBI Database System Rev Implement Rep. 2015. PMID: 26571286
-
Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity.Mol Aspects Med. 2019 Apr;66:49-61. doi: 10.1016/j.mam.2018.11.001. Epub 2018 Nov 27. Mol Aspects Med. 2019. PMID: 30472165 Review.
-
Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.Clin Med Insights Endocrinol Diabetes. 2023 Dec 25;16:11795514231220780. doi: 10.1177/11795514231220780. eCollection 2023. Clin Med Insights Endocrinol Diabetes. 2023. PMID: 38148756 Free PMC article. Review.
-
Drug treatments to restore vascular function and diabesity.Ann Pharm Fr. 2013 Jan;71(1):27-33. doi: 10.1016/j.pharma.2012.09.001. Epub 2012 Oct 1. Ann Pharm Fr. 2013. PMID: 23348853 Review.
-
Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options.Pharmacol Res. 2017 Jun;120:226-241. doi: 10.1016/j.phrs.2017.04.009. Epub 2017 Apr 10. Pharmacol Res. 2017. PMID: 28408314 Review.
References
-
- M. Brauer, B. Casadei, R.A. Harrington, R. Kovacs, K. Sliwa; Group WHFAPE, Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. Circulation 143(14), e800–e804 (2021) - PubMed - DOI
-
- J. Pearson-Stuttard, Y.J. Cheng, J. Bennett, E.P. Vamos, B. Zhou, J. Valabhji et al. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diab. Endocrinol. 10(1), 46–57 (2022) - DOI
-
- M.A. Nagi, H. Ahmed, M.A.A. Rezq, S. Sangroongruangsri, U. Chaikledkaew, Z. Almalki, M. Thavorncharoensap, Economic costs of obesity: a systematic review. Int J. Obes. 48(1), 33–43 (2024) - DOI
Publication types
LinkOut - more resources
Full Text Sources